When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive and liver disease 2021-02, Vol.53 (2), p.258-260
Hauptverfasser:	Tron, C, Lemaitre, F, Boisteau, Emeric, Sourd, S Le, Lièvre, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Human health and pathology Hépatology and Gastroenterology Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	260
container_issue	2
container_start_page	258
container_title	Digestive and liver disease
container_volume	53
creator	Tron, C Lemaitre, F Boisteau, Emeric Sourd, S Le Lièvre, A
description
doi_str_mv	10.1016/j.dld.2020.11.004
format	Article
fullrecord	<record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03023826v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S159086582031001X</els_id><sourcerecordid>2464150638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-c1fda4e7f4fe2a2ca7e54941f89d43c5605ad7b99fd426bf7a57f052c5d8bf633</originalsourceid><addsrcrecordid>eNp9kctu1DAUQCMEoqXwAWyQl3SRwe8ksKpaoEgjwaKIpeWxryceJXGwnUrzB3w2nqZ0ycq-1rln4VNVbwneEEzkh8PGDnZDMS0z2WDMn1XnpG3amglJn5e76HDdStGeVa9SOmBMiRT4ZXXGGKUdbcR59edXDxPqYZj9tEe5BzT6KUSfjyg4NOvsYcoJjfqI-iXmldCHB-IjuiuT0QmQCxHd_LhBc7GFfHyQ6ckiUbthCTEsURs_nLajnmHJ3iAblz0aw-RzkU3719ULp4cEbx7Pi-rnl89317f19vvXb9dX29pwhnNtiLOaQ-O4A6qp0Q0I3nHi2s5yZoTEQttm13XOcip3rtGicVhQI2y7c5Kxi-py9fZ6UHP0o45HFbRXt1dbdXrDDFPWUnlPCvt-ZecYfi-Qshp9MjAMeoKwJEW55ERgydqCkhU1MaQUwT25CVanWOqgSix1iqUIUSVW2Xn3qF92I9injX91CvBpBaB8yL2HqJIpPQxYH8FkZYP_j_4vix6mbw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2464150638</pqid></control><display><type>article</type><title>When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring</title><source>Elsevier ScienceDirect Journals</source><creator>Tron, C ; Lemaitre, F ; Boisteau, Emeric ; Sourd, S Le ; Lièvre, A</creator><creatorcontrib>Tron, C ; Lemaitre, F ; Boisteau, Emeric ; Sourd, S Le ; Lièvre, A</creatorcontrib><identifier>ISSN: 1590-8658</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2020.11.004</identifier><identifier>PMID: 33229275</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Human health and pathology ; Hépatology and Gastroenterology ; Life Sciences</subject><ispartof>Digestive and liver disease, 2021-02, Vol.53 (2), p.258-260</ispartof><rights>2020 Editrice Gastroenterologica Italiana S.r.l.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-c1fda4e7f4fe2a2ca7e54941f89d43c5605ad7b99fd426bf7a57f052c5d8bf633</citedby><cites>FETCH-LOGICAL-c430t-c1fda4e7f4fe2a2ca7e54941f89d43c5605ad7b99fd426bf7a57f052c5d8bf633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S159086582031001X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33229275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03023826$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Tron, C</creatorcontrib><creatorcontrib>Lemaitre, F</creatorcontrib><creatorcontrib>Boisteau, Emeric</creatorcontrib><creatorcontrib>Sourd, S Le</creatorcontrib><creatorcontrib>Lièvre, A</creatorcontrib><title>When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><subject>Human health and pathology</subject><subject>Hépatology and Gastroenterology</subject><subject>Life Sciences</subject><issn>1590-8658</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUQCMEoqXwAWyQl3SRwe8ksKpaoEgjwaKIpeWxryceJXGwnUrzB3w2nqZ0ycq-1rln4VNVbwneEEzkh8PGDnZDMS0z2WDMn1XnpG3amglJn5e76HDdStGeVa9SOmBMiRT4ZXXGGKUdbcR59edXDxPqYZj9tEe5BzT6KUSfjyg4NOvsYcoJjfqI-iXmldCHB-IjuiuT0QmQCxHd_LhBc7GFfHyQ6ckiUbthCTEsURs_nLajnmHJ3iAblz0aw-RzkU3719ULp4cEbx7Pi-rnl89317f19vvXb9dX29pwhnNtiLOaQ-O4A6qp0Q0I3nHi2s5yZoTEQttm13XOcip3rtGicVhQI2y7c5Kxi-py9fZ6UHP0o45HFbRXt1dbdXrDDFPWUnlPCvt-ZecYfi-Qshp9MjAMeoKwJEW55ERgydqCkhU1MaQUwT25CVanWOqgSix1iqUIUSVW2Xn3qF92I9injX91CvBpBaB8yL2HqJIpPQxYH8FkZYP_j_4vix6mbw</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Tron, C</creator><creator>Lemaitre, F</creator><creator>Boisteau, Emeric</creator><creator>Sourd, S Le</creator><creator>Lièvre, A</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>202102</creationdate><title>When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring</title><author>Tron, C ; Lemaitre, F ; Boisteau, Emeric ; Sourd, S Le ; Lièvre, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-c1fda4e7f4fe2a2ca7e54941f89d43c5605ad7b99fd426bf7a57f052c5d8bf633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Human health and pathology</topic><topic>Hépatology and Gastroenterology</topic><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tron, C</creatorcontrib><creatorcontrib>Lemaitre, F</creatorcontrib><creatorcontrib>Boisteau, Emeric</creatorcontrib><creatorcontrib>Sourd, S Le</creatorcontrib><creatorcontrib>Lièvre, A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tron, C</au><au>Lemaitre, F</au><au>Boisteau, Emeric</au><au>Sourd, S Le</au><au>Lièvre, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2021-02</date><risdate>2021</risdate><volume>53</volume><issue>2</issue><spage>258</spage><epage>260</epage><pages>258-260</pages><issn>1590-8658</issn><eissn>1878-3562</eissn><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33229275</pmid><doi>10.1016/j.dld.2020.11.004</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1590-8658
ispartof	Digestive and liver disease, 2021-02, Vol.53 (2), p.258-260
issn	1590-8658 1878-3562
language	eng
recordid	cdi_hal_primary_oai_HAL_hal_03023826v1
source	Elsevier ScienceDirect Journals
subjects	Human health and pathology Hépatology and Gastroenterology Life Sciences
title	When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T21%3A13%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20helping%20the%20minority%20of%20patients%20may%20hurt%20the%20majority:%20The%20case%20for%20DPD%20phenotyping%20and%205-fluorouracil%20therapeutic%20drug%20monitoring&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Tron,%20C&rft.date=2021-02&rft.volume=53&rft.issue=2&rft.spage=258&rft.epage=260&rft.pages=258-260&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2020.11.004&rft_dat=%3Cproquest_hal_p%3E2464150638%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2464150638&rft_id=info:pmid/33229275&rft_els_id=S159086582031001X&rfr_iscdi=true